Review article · 30 Jun 2020
EditorialPublished 29 Dec 2015
An Example of Controversies on Anti-fibrosis Therapies in Cardiovascular Diseases: Transforming Growth Factor β1
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, USA
Subjects
CardiologySimilar by topic
Article · 2017
Expression and Importance of Interleukin-17 and Transforming Growth Factor-Ã?ŽÃ?² in the Spleens of Hypersplenic Rats
Research article · 2017
Expression and Importance of Interleukin-17 and Transforming Growth Factor-β in the Spleens of Hypersplenic Rats
Short communication · 31 Jan 2018
Growth differentiation factor 15 in cardiovascular diseases: Are we needed novel biomarker?
Conference abstract · 20 Aug 2012
Reduction of chronic rejection of renal allografts by anti-transforming growth factor beta antibody therapy
More from this journal
The newest in Cardiovascular Therapy: Open Access.
Research article · 15 Feb 2018
Peripartum Cardiomyopathy about 16 Cases at the Peace Hospital of Ziguinchor in Senegal
Case report · 28 Aug 2017
Peripartum Cardiomyopathy: Four Case Reports with Different Outcomes
Short communication · 30 Jun 2017
Why is Cardiac Morbidity and Mortality Greater Around Christmas, New Year’s, Monday Mornings and in the Morning Hours: Potential Roles of Unrecognized Ionized Hypomagnesemia and Release of Ceramides?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Therapy: Open Access
- SubjectCardiology
- BylineArticles whose byline prints “Masao Kakoki”
